With the Latin American pharma market expected to grow 10% in the next two years, it pays to gain access. But how? Salvador Alvarez Rio, Senior Engagement Manager at PRECISIONadvisors, explains the power of patient advocacy groups to insist on reimbursement for high-cost advanced medicines.
Dystrophic Epidermolysis Bullosa (DEB) is an ultra rare genetic disease with no currently approved treatments. In this Access90, Precision's Will Derrickson discusses the unique market access considerations for Krystal Biotech's anticipated launch of B-VEC, a non-invasive treatment for DEB and the first ever topical gene therapy.
Latin America is a $43 billion pharma market—and regional dynamics matter. PRECISIONadvisor’s dedicated team of experts can help navigate local market access and pricing. Discover what that means for your brand.
The May Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
With the MHRA becoming the standalone regulator of medicines in Great Britain, Precision research aims to shed light on market access in the post-Brexit era, as well as key implications for manufacturers. In this Access90, Precision's Katherine Ka Wan Leong discusses two research posters the PRECISION team will be presenting at ISPOR US this year focusing on the UK access landscape.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
